These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20228826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of ohmefentanyl stereoisomers on phosphorylation of cAMP- response element binding protein in cultured rat hippocampal neurons.
    Gao C, Chen LW, Tao YM, Chen J, Xu XJ, Chi ZQ.
    Acta Pharmacol Sin; 2003 Dec; 24(12):1253-8. PubMed ID: 14653953
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
    Liu ZH, He Y, Jin WQ, Chen XJ, Shen QX, Chi ZQ.
    Life Sci; 2004 Apr 30; 74(24):3001-8. PubMed ID: 15051423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H, Wang X, Wang J, Rothman RB.
    Synapse; 2004 Jun 01; 52(3):209-17. PubMed ID: 15065220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):306-11. PubMed ID: 18353307
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
    Xu H, Lu YF, Rothman RB.
    Synapse; 2003 Jan 28; 47(1):1-9. PubMed ID: 12422367
    [Abstract] [Full Text] [Related]

  • 13. Differential opioid agonist regulation of the mouse mu opioid receptor.
    Blake AD, Bot G, Freeman JC, Reisine T.
    J Biol Chem; 1997 Jan 10; 272(2):782-90. PubMed ID: 8995364
    [Abstract] [Full Text] [Related]

  • 14. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
    Lee KO, Akil H, Woods JH, Traynor JR.
    Eur J Pharmacol; 1999 Aug 13; 378(3):323-30. PubMed ID: 10493109
    [Abstract] [Full Text] [Related]

  • 15. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D, Raehal KM, Bilsky EJ, Sadée W.
    J Neurochem; 2001 Jun 13; 77(6):1590-600. PubMed ID: 11413242
    [Abstract] [Full Text] [Related]

  • 16. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
    Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadée W.
    J Pharmacol Exp Ther; 2004 Feb 13; 308(2):512-20. PubMed ID: 14600246
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
    Wallisch M, Nelson CS, Mulvaney JM, Hernandez HS, Smith SA, Olsen GD.
    Biochem Pharmacol; 2007 Jun 01; 73(11):1818-28. PubMed ID: 17343833
    [Abstract] [Full Text] [Related]

  • 18. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M, Kumar P, Sunkaraneni S, Sirohi S, Walker EA, Yoburn BC.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):92-101. PubMed ID: 17349996
    [Abstract] [Full Text] [Related]

  • 19. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
    Capeyrou R, Riond J, Corbani M, Lepage JF, Bertin B, Emorine LJ.
    FEBS Lett; 1997 Sep 29; 415(2):200-5. PubMed ID: 9350996
    [Abstract] [Full Text] [Related]

  • 20. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR, Nahorski SR.
    Mol Pharmacol; 1995 Apr 29; 47(4):848-54. PubMed ID: 7723747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.